Lv1
50 积分 2025-04-01 加入
The association of hepatic steatosis and fibrosis with heart failure and mortality
10天前
已完结
Non-alcoholic fatty liver disease and increased risk of all-cause mortality in elderly patients admitted for acute heart failure
10天前
已完结
Current Burden of MASLD, MetALD, and Hepatic Fibrosis among US Adults with Prediabetes and Diabetes, 2017-2023
10天前
已完结
Current Burden of Lean Metabolic Dysfunction‐Associated Steatotic Liver Disease Among US Adults, 2017–2023
10天前
已完结
Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach
11天前
已完结
Liver stiffness as a cornerstone in heart disease risk assessment
11天前
已完结
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
13天前
已完结
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
13天前
已完结
Non-alcoholic fatty liver disease is associated with a worse prognosis in patients with heart failure: A pool analysis
13天前
已完结
Letter regarding the article ‘Efficacy and safety of angiotensin receptor–neprilysin inhibition in heart failure patients with end‐stage kidney disease on maintenance dialysis: A systematic review and meta‐analysis’
13天前
已完结
皖公网安备34019202002308
